Connie Chang

Chief Operating Officer at ONL Therapeutics, Inc.

Health Technology

Consumer Services

Profile

Connie Chang is currently the Chief Operating Officer at ONL Therapeutics, Inc. Her former position was Vice President-Corporate Affairs at Millendo Therapeutics, Inc. She received her undergraduate degree from Harvard University and her MBA from Harvard Business School.

Connie Chang active positions

Companies	Position	Start
ONL Therapeutics, Inc. ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI.	Chief Operating Officer	19/01/2021

All active positions of Connie Chang

Former positions of Connie Chang

Companies	Position	End
MILLENDO THERAPEUTICS	Corporate Officer/Principal	-

See the detail of Connie Chang's experience

Training of Connie Chang

Harvard University	Undergraduate Degree
Harvard Business School	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Connie Chang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Millendo Therapeutics, Inc. Millendo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Millendo Therapeutics, Inc. is a biopharmaceutical company, which engages in seeking distinct and transformative treatments where there is a significant unmet medical need. The company was founded by Julia C. Owens in January 2012 and is headquartered in Ann Arbor, MI.	Health Technology
ONL Therapeutics, Inc. ONL Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ONL Therapeutics, Inc. develops biopharmaceutical services. It protects and improves the vision of patients with a range of retinal diseases and conditions, including retinal detachment and both the wet and dry forms of age-related macular degeneration. The company was founded by David Zacks and Jeffery Jamison in 2006 and is headquartered in Ann Arbor, MI.	Health Technology